Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Equity Average (2020 - 2025)

Historic Equity Average for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to -$22.8 million.

  • Celularity's Equity Average fell 20110.89% to -$22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.8 million, marking a year-over-year decrease of 20110.89%. This contributed to the annual value of $24.9 million for FY2024, which is 7923.92% down from last year.
  • Celularity's Equity Average amounted to -$22.8 million in Q3 2025, which was down 20110.89% from -$15.5 million recorded in Q2 2025.
  • Celularity's 5-year Equity Average high stood at $181.6 million for Q4 2022, and its period low was -$285.5 million during Q1 2021.
  • Moreover, its 5-year median value for Equity Average was $35.6 million (2023), whereas its average is $44.0 million.
  • Its Equity Average has fluctuated over the past 5 years, first tumbled by 96987.41% in 2021, then surged by 54408.11% in 2022.
  • Celularity's Equity Average (Quarter) stood at $97.8 million in 2021, then soared by 85.62% to $181.6 million in 2022, then tumbled by 80.39% to $35.6 million in 2023, then tumbled by 63.32% to $13.1 million in 2024, then crashed by 274.56% to -$22.8 million in 2025.
  • Its last three reported values are -$22.8 million in Q3 2025, -$15.5 million for Q2 2025, and $1.7 million during Q1 2025.